AsianScientist (May 14, 2014) – Agilent Technologies Inc. will collaborate with Seoul National University (SNU) on a new research center that will support the College of Pharmacy’s New Drug Development Center.
As stated in a memorandum of understanding signed by Seoul National University’s College of Pharmacy and Agilent, the collaboration aims to conduct drug metabolism studies, develop new compounds and conduct clinical tests for drugs.
“The College of Pharmacy at the Seoul National University has a long tradition of driving innovation,” said professor Lee Bong-Jin, dean of the college. “We have been leading Korea’s pharmaceutical industry through the strategic use of technology and driving the development of new drugs.”
Agilent will provide bio-analytical instruments and expertise in pharmaceutical drug testing and multi-omic biological systems. The jointly established research center will also serve as Agilent’s reference site for drug development.
This new research facility will be located at the New Drug Development Center at SNU’s College of Pharmacy. The six-story center houses facilities for analysis, efficacy testing, and medicinal ingredient research; and also contains a medicinal chemistry laboratory.
—–
Source: Agilent Technologies.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
